Skip to content

Clinical Efficacy Observation and fMRI Brain Mechanism Study of Nape Seven Needles in the Treatment of Post-Stroke Dysphagia

Clinical Efficacy Observation and fMRI Brain Mechanism Study of Nape Seven Needles in the Treatment of Post-Stroke Dysphagia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000209
Enrollment
Unknown
Registered
2025-01-31
Start date
2024-12-10
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia after stroke

Interventions

Control Group:Basic Treatment
Acupuncture Treatment
Experimental Group:Basic Treatment
Nape Seven Needles Treatment

Sponsors

The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients meeting the diagnostic criteria for stroke. 2. Patients diagnosed with dysphagia through videofluoroscopic swallowing study (VFSS). 3. Current dietary intake is restricted with a Watian drinking water test score of Grade II or above. 4. Mini-Mental State Examination (MMSE) score of 24 or higher demonstrating sufficient cognitive ability to understand and follow simple instructions from the treatment provider. 5. Aged between 35 and 70 years regardless of gender. 6. Onset of stroke can be determined and occurred within 90 days. 7. Clear consciousness and stable vital signs. 8. No severe complications with good tolerance and compliance for acupuncture treatment. 9. Patients or their families agree to voluntarily participate in the study with the patient or their legal representative signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Dysphagia caused by conditions other than stroke. 2. Patients with other diseases affecting swallowing function (e.g. neuromuscular diseases nasopharyngeal cancer head and neck cancer). 3. Pregnant or breastfeeding women. 4. Patients with severe primary chronic diseases involving the heart liver kidneys hematopoietic system or endocrine system. 5. Patients with severe dementia mental disorders or severe speech comprehension impairments who are unable to follow instructions from treatment personnel. 6. Patients with diseases associated with bleeding tendencies. 7. Patients who have received other types of treatment for dysphagia within the past month.

Design outcomes

Primary

MeasureTime frame
Watian Drinking Water Test;Vertebrobasilar Artery Hemodynamics;Standard Swallowing Function Assessment;

Secondary

MeasureTime frame
Surface Electromyography (sEMG) of Swallowing-Related Muscles;Swallowing-Specific Quality of Life Scale (SWAL-QOL);Mylohyoid Muscle Movement;

Countries

China

Contacts

Public ContactJia Hongling

The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine

jiahl1969@163.com18254178199

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026